• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    S&P Biotech SPDR (NY: XBI )

    103.01 +0.57 (+0.56%)
    Official Closing Price Updated: 4:10 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about S&P Biotech SPDR

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Should I Be Worried? Stock Market (And Sentiment Results)…
    We are aggressively putting money to work in individual companies that are excessively undervalued relative to what we believe their normalized earnings power will look like as their recoveries... 
    Via Talk Markets
    If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
    Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. 
    Via InvestorPlace
    Exposures Product Safety
    Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
    Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024. 
    Via InvestorPlace
    For Biotech Stocks To Move Higher, This Must Move Lower
    While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure. 
    Via Talk Markets
    Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
    Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. 
    Via Benzinga
    AskSlim Market Week - Friday, March 28
    An analysis and commentary on the financial markets. 
    Via Talk Markets
    AskSlim Market Week - Friday, April 26
    An analysis and commentary on the financial markets. 
    Via Talk Markets
    3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
    Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now. 
    Via InvestorPlace
    Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
    Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
    Via Talk Markets
    Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
    Stocks initially rose on positive jobless claims report, but dropped later as Fed officials expressed doubts about interest rate cuts this year. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    5 Healthcare Stocks to Buy for 2024
    Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Healthcare And Biotech Stocks Review: Q1 2024 Performance
    We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight... 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    2 Top Biotech Buyout Candidates
    Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be... 
    Via Talk Markets
    3 Top ETFs I Plan to Buy in April
    These ETFs are easy, low-cost ways to invest in certain themes. 
    Via The Motley Fool
    Topics ETFs
    3 Biotech Stocks to Buy on the Dip: March 2024
    Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
    Via InvestorPlace
    Tuesday Talk: Big-Tech Under Attack
    On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs. 
    Via Talk Markets
    Biotechnology And Healthcare, A Bit Of A Lull
    Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
    Via Talk Markets
    3 Biotech ETFs Overdue for a Bounce
    The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback. 
    Via InvestorPlace
    Topics ETFs
    It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
    Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
    Via Talk Markets
    Are We Listening To The Market's Message?
    This week's video features chart/fact-based Q & A covering major stock market indexes, ETFs, the economy, homebuilders, regional banks, semiconductors, value stocks, energy stocks, biotech, and more. 
    Via Talk Markets
    Topics ETFs Economy
    Exposures Economy
    “Advance Is Advancing” Stock Market (And Sentiment Results)…
    Commentary on the stock market, economy, inflation, biotech, and auto sales, as well as a deep dive into Advance Auto Parts. 
    Via Talk Markets
    Topics Economy
    Exposures Economy Interest Rates
    Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
    The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined... 
    Via Benzinga
    TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
    The company reported in-line sales for the fourth quarter, but shares soared by double digits. 
    Via Investor's Business Daily
    Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
    To gain an edge, this is what you need to know today. 
    Via Benzinga
    Topics Artificial Intelligence Economy
    Exposures Artificial Intelligence Interest Rates
    ETF Theme: Range-Bound
    Here is the fund for the emerging markets, which is not only range-bound but seems to be following a regular time pattern. 
    Via Talk Markets
    Topics ETFs
    Healthcare Stocks Are Looking Better But What About Biotech?
    Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. 
    Via Talk Markets
    Favoring IWM, XBI, And KRE
    It's time to employ ratios. Just like I utilize sector ratios such as XLF to XLU, XLY to XLP, or SPY to TLT, this is the time to look at IWM in comparison to the SPY. 
    Via Talk Markets
    Sunday ETF Review, Feb. 4, 2024
    Examining my 
    Via Talk Markets
    Topics ETFs
    Biotech And Medtech Portfolio Notes On A Fed Day
    The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
    There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.